Embecta Corp. Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| EMBC | RMD | |
|---|---|---|
| Market Cap | $282.73 million | $31.92 billion |
| Revenue (TTM) | — | $5.54 billion |
| Net Income (TTM) | — | $1.52 billion |
RMD leads on 1 of 1 size & scale factors.
Valuation
| EMBC | RMD | |
|---|---|---|
| P/E Ratio | — | 21.22 |
| Price / Book | — | 4.92 |
| Price / Sales | — | 5.76 |
EMBC and RMD split the valuation factors evenly.
Profitability
| EMBC | RMD | |
|---|---|---|
| Net Margin | — | 27.44% |
| Return on Equity | — | 23.41% |
EMBC and RMD split the profitability factors evenly.
Dividend
| EMBC | RMD | |
|---|---|---|
| Dividend Yield | 0.80% | 1.20% |
| Payout Ratio | — | 25.46 |
RMD leads on 1 of 1 dividend factors.
Risk & Sentiment
| EMBC | RMD | |
|---|---|---|
| Short Interest | 2.25% | 4.02% |
EMBC leads on 1 of 1 risk & sentiment factors.
Dig deeper: EMBC overview, EMBC financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.